ACAD 8-K 2026-09-24
ACADIA PHARMACEUTICALS INC (ACAD) 8-K dated 2026-09-24 — accession 0001193125-26-401157.
ACADIA PHARMACEUTICALS INC (ACAD) is a biotechnology company listed on US.
ACADIA PHARMACEUTICALS INC filed a 8-K on 2026-09-24. Accession 0001193125-26-401157.
This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ACAD revenue for 2025-12-31 was $1.07B. Net income was $391.0M. Revenue was up 11.9% from 2024-12-31 to 2025-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 8.6.
Not investment advice. The ACAD SEC hub lists recent forms. The stock page is the research view.